|
Volumn 44, Issue 21, 2001, Pages 3463-3468
|
A new class of ibuprofen derivatives with reduced gastrotoxicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 [(3 BENZENESULFONYL)FUROXAN 4 YLOXY]PROPYL 2 (4 ISOBUTYLPHENYL)PROPIONATE;
3 [3 (PHENYLTHIO)FUROXAN 4 YLOXY]PROPYL 2 (4 ISOBUTYLPHENYL)PROPIONATE;
CARBOXYL GROUP;
CARRAGEENAN;
FURAZAN DERIVATIVE;
FUROXAN DERIVATIVE;
IBUPROFEN;
IBUPROFEN DERIVATIVE;
NITRIC OXIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG HYDROLYSIS;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MALE;
NONHUMAN;
PAW EDEMA;
RAT;
STOMACH MUCOSA;
STOMACH ULCER;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION INHIBITION;
ULCEROGENESIS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CARRAGEENAN;
CYCLIC N-OXIDES;
EDEMA;
GASTRIC MUCOSA;
HUMANS;
IBUPROFEN;
MALE;
NITRIC OXIDE DONORS;
OXADIAZOLES;
PEPTIC ULCER;
PLATELET AGGREGATION INHIBITORS;
RATS;
RATS, WISTAR;
|
EID: 0035846069
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm0108799 Document Type: Article |
Times cited : (79)
|
References (29)
|